Penumbra share price today

(PEN)

Penumbra share price is $242.54 & ₹20,610.08 as on 21 Dec 2024, 2.30 'hrs' IST

$242.54

▲

-0.98

(-0.4%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Penumbra share price in Dollar and Rupees. Guide to invest in Penumbra from India. Also see the sentimental analysis on Indian investors investing in Penumbra. Get details on the Indian mutual funds that are investing in Penumbra. Get Analyst recommendations and forecasts along with all the Penumbra's financials.

Penumbra share price movements

Today's Low: $241.27
Today's High: $245.47
$242.54
0.52%
Downside
Day's Volatility :1.71%
Upside
1.19%
52 Weeks Low: $148.00
52 Weeks High: $277.34
$242.54
38.98%
Downside
52 Weeks Volatility :46.64%
Upside
12.55%

Penumbra Returns

Period	Penumbra Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	24.44%	-10.6%	0.0%
6 Months	39.07%	-6.0%	0.0%
1 Year	-6.77%	2.2%	0.0%
3 Years	-13.18%	-0.9%	-21.1%

Penumbra Key Statistics

in dollars & INR

Previous Close	$243.52
Open	$242.0
Today's High	$245.465
Today's Low	$241.27
Market Capitalization	$9.3B
Today's Volume	$759.7K
52 Week High	$277.34
52 Week Low	$148.0
Revenue TTM	$1.2B
EBITDA	$102.5M
Earnings Per Share (EPS)	$0.88
PE Ratio	276.73
Profit Margin	2.97%
Quarterly Earnings Growth YOY	2.26%
Return On Equity TTM	3.13%

How to invest in Penumbra from India?

It is very easy for Indian residents to invest directly in Penumbra from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Penumbra stock in both Indian Rupees (INR) and US Dollars (USD). Search for Penumbra or PEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Penumbra or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Penumbra shares which would translate to 0.004 fractional shares of Penumbra as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Penumbra, in just a few clicks!

Returns in Penumbra for Indian investors in Rupees

Investment Value

₹1,00,000

Penumbra investment value today

Current value as on today

₹95,430

Returns

₹4,570

(-4.57%)

Returns from Penumbra Stock

₹6,766 (-6.77%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Penumbra

80%

Period: Sep 23, 2024 to Dec 22, 2024. Change in 30 Days versus previous period

Search volume for Penumbra on INDmoney from India has grown in the last 30 days as on Dec 23, 2024. 80% more investors are searching Penumbra in the last 30 days versus the previous period.

Global Institutional Holdings in Penumbra

FMR Inc
15.36%
BlackRock Inc
11.09%
Vanguard Group Inc
9.58%
T. Rowe Price Associates, Inc.
5.17%
Champlain Investment Partners, LLC
4.03%
State Street Corp
3.22%

Analyst Recommendation on Penumbra

Buy

70%Buy

30%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Penumbra(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Penumbra

What analysts predicted

Upside of 6.21%

Current:

$242.54

Target:

$257.60

Insights on Penumbra

Price Movement
In the last 3 months, PEN stock has moved up by 24.4%
Increasing Revenue
Revenue is up for the last 3 quarters, 278.65M → 301.03M (in $), with an average increase of 3.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -60.2M → 29.52M (in $), with an average increase of 303.9% per quarter
PEN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.1% return, outperforming this stock by 65.3%
PEN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 108.2% return, outperforming this stock by 120.2%
Price to Sales
ForPEN every $1 of sales, investors are willing to pay $8.1, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Penumbra Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$444.9M	↑ 33.31%
Net Income	$6.6M	↑ 41.74%
Net Profit Margin	1.48%	↑ 0.08%

	FY19	Y/Y Change
Revenue	$547.4M	↑ 23.03%
Net Income	$48.5M	↑ 634.1%
Net Profit Margin	8.85%	↑ 7.37%

	FY20	Y/Y Change
Revenue	$560.4M	↑ 2.38%
Net Income	$-19.3M	↓ 139.74%
Net Profit Margin	-3.44%	↓ 12.29%

	FY21	Y/Y Change
Revenue	$747.6M	↑ 33.4%
Net Income	$2.6M	↓ 113.62%
Net Profit Margin	0.35%	↑ 3.79%

	FY22	Y/Y Change
Revenue	$847.1M	↑ 13.32%
Net Income	$-2.0M	↓ 176.32%
Net Profit Margin	-0.24%	↓ 0.59%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 24.95%
Net Income	$91.0M	↓ 4643.16%
Net Profit Margin	8.59%	↑ 8.83%

	Q2 FY23	Q/Q Change
Revenue	$261.5M	↑ 8.33%
Net Income	$19.0M	↑ 121.44%
Net Profit Margin	7.25%	↑ 3.7%

	Q3 FY23	Q/Q Change
Revenue	$270.9M	↑ 3.61%
Net Income	$9.2M	↓ 51.4%
Net Profit Margin	3.4%	↓ 3.85%

	Q4 FY23	Q/Q Change
Revenue	$284.7M	↑ 5.07%
Net Income	$54.2M	↑ 488.43%
Net Profit Margin	19.05%	↑ 15.65%

	Q1 FY24	Q/Q Change
Revenue	$278.7M	↓ 2.12%
Net Income	$11.0M	↓ 79.71%
Net Profit Margin	3.95%	↓ 15.1%

	Q2 FY24	Q/Q Change
Revenue	$299.4M	↑ 7.45%
Net Income	$-60.2M	↓ 647.17%
Net Profit Margin	-20.11%	↓ 24.06%

	Q3 FY24	Q/Q Change
Revenue	$301.0M	↑ 0.55%
Net Income	$29.5M	↓ 149.05%
Net Profit Margin	9.81%	↑ 29.92%

	FY18	Y/Y Change
Profit	$292.5M	↑ 34.72%

	FY19	Y/Y Change
Profit	$372.0M	↑ 27.15%

	FY20	Y/Y Change
Profit	$338.2M	↓ 9.08%

	FY21	Y/Y Change
Profit	$475.4M	↑ 40.57%

	FY22	Y/Y Change
Profit	$535.2M	↑ 12.58%

	FY23	Y/Y Change
Profit	$682.6M	↑ 27.55%

	Q2 FY23	Q/Q Change
Profit	$166.9M	↑ 10.45%

	Q3 FY23	Q/Q Change
Profit	$177.7M	↑ 6.51%

	Q4 FY23	Q/Q Change
Profit	$187.0M	↑ 5.22%

	Q1 FY24	Q/Q Change
Profit	$178.7M	↓ 4.46%

	Q2 FY24	Q/Q Change
Profit	$160.3M	↓ 10.25%

	Q3 FY24	Q/Q Change
Profit	$200.3M	↑ 24.92%

	FY18	Y/Y Change
Operating Cash Flow	$28.8M	↑ 127.0%
Investing Cash Flow	$-385.0K	↓ 99.5%
Financing Cash Flow	$-9.8M	↓ 109.41%

	FY19	Y/Y Change
Operating Cash Flow	$26.7M	↓ 7.48%
Investing Cash Flow	$-12.7M	↑ 3201.56%
Financing Cash Flow	$-9.0M	↓ 8.72%

	FY20	Y/Y Change
Operating Cash Flow	$-33.2M	↓ 224.73%
Investing Cash Flow	$-104.1M	↑ 719.36%
Financing Cash Flow	$134.9M	↓ 1605.94%

	FY21	Y/Y Change
Operating Cash Flow	$9.5M	↓ 128.58%
Investing Cash Flow	$-21.7M	↓ 79.13%
Financing Cash Flow	$836.0K	↓ 99.38%

	FY22	Y/Y Change
Operating Cash Flow	$-55.7M	↓ 685.78%
Investing Cash Flow	$54.8M	↓ 352.08%
Financing Cash Flow	$11.6M	↑ 1290.19%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$17.1M	↑ 30.24%
Investing Cash Flow	$-6.7M	↓ 162.28%
Financing Cash Flow	$8.7M	↑ 531.83%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$30.8M	↑ 80.38%
Investing Cash Flow	$-40.4M	↑ 504.95%
Financing Cash Flow	$212.0K	↓ 97.56%

Penumbra Technicals Summary

Sell

Neutral

Buy

Penumbra is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Penumbra Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Penumbra Inc	-0.87%	39.07%	-6.77%	-13.18%	47.32%
Stryker Corporation	-5.28%	7.53%	21.91%	34.83%	73.83%
Boston Scientific Corp.	-0.34%	15.96%	58.87%	106.28%	96.53%
Edwards Lifesciences Corp.	4.97%	-17.03%	-1.93%	-42.71%	-4.81%
Abbott Laboratories	-3.3%	8.48%	4.58%	-19.25%	30.88%
Medtronic Plc	-5.5%	-0.01%	-1.54%	-22.41%	-28.02%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Penumbra Inc	276.73	276.73	-62.27	2.79	0.03	0.03	NA	28.79
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Penumbra Inc	Buy	$9.3B	47.32%	276.73	2.97%
Stryker Corporation	Buy	$136.1B	73.83%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.53%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-4.81%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.88%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.02%	24.46	12.06%

About Penumbra

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.

Organization	Penumbra
Employees	4200
CEO	Mr. Adam Elsesser J.D.
Industry	Health Technology

Management People of Penumbra

Name	Title
Mr. Adam Elsesser J.D.	Co-Founder, Chairman, President & CEO
Dr. Arani Bose M.D.	Co-Founder & Director
Ms. Maggie S. Yuen	Chief Financial Officer
Mr. Lambert Shiu	Chief Accounting Officer
Ms. Johanna Roberts J.D.	Executive VP, General Counsel & Secretary
Mr. Ben Sorci	Executive Vice President of Operations
Mr. Pankaj Tiwari	Executive VP & Chief Information Officer
Ms. Jee Hamlyn-Harris	Investor Relations Officer
Mr. Ben Tompkins	Executive Vice President of Development & Compliance
Ms. Shruthi Narayan	Executive VP & GM of Interventional

Important FAQs about investing in Penumbra from India :

What is Penumbra share price today?

Penumbra share price today stands at $242.54, Open: $242.00 ; Previous Close: $243.52 ; High: $245.47 ; Low: $241.27 ; 52 Week High: $277.34 ; 52 Week Low: $148.00. The stock opens at $242.00, after a previous close of $243.52. The stock reached a daily high of $245.47 and a low of $241.27, with a 52-week high of $277.34 and a 52-week low of $148.00.

Can Indians buy Penumbra shares?

Yes, Indians can invest in the Penumbra (PEN) from India.

With INDmoney, you can buy Penumbra at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Penumbra at zero transaction cost.

How can I buy Penumbra shares from India?

It is very easy to buy Penumbra from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Penumbra be purchased?

Yes, you can buy fractional shares of Penumbra with INDmoney app.

What are the documents required to start investing in Penumbra stocks?

To start investing in Penumbra, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.